Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol

INTRODUCTION: Community-acquired pneumonia (CAP) continues to be a major health problem worldwide and is one of the main reasons for prescribing antibiotics. However, the causative agent is often not identified, resulting in antibiotic overtreatment, which is a key driver of antimicrobial resistance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Abelenda-Alonso, Gabriela, Rombauts, Alexander, Gudiol, Carlota, Meije, Yolanda, Clemente, Mercedes, Ortega, Lucía, Ardanuy, Carmen, Niubó, Jordi, Padullés, Ariadna, Videla, Sebastian, Tebe, Cristian, Carratalà, Jordi
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Infectious Diseases
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7443276/
https://ncbi.nlm.nih.gov/pubmed/32819999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-038957
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados